Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Nitrostat 0.3mg sublingual tablets (Canada)
Section 19A approved medicine
(Approval lapsed) Nitrostat 0.3mg sublingual tablets (Canada)
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 008 422 348
Upjohn Australia Pty Ltd ABN 50 629 389 911
Upjohn Australia Pty Ltd ABN 50 629 389 911
Phone
1800 675 229
Approved until
Status
Expired
Medicines in short supply/unavailable
ANGININE glyceryl trinitrate 600microgram tablet bottle - ARTG 227783
LYCINATE glyceryl trinitrate 600microgram tablet bottle - ARTG 227784
LYCINATE glyceryl trinitrate 600microgram tablet bottle - ARTG 227784
Indication(s)
NITROSTAT is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.